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Abstract: Monoterpenes are plant secondary metabolites, widely used in industrial processes as
precursors of important aroma compounds, such as vanillin and (−)-menthol. However, the physico-
chemical properties of monoterpenes make difficult their conventional conversion into value-added
aromas. Biocatalysis, either by using whole cells or enzymes, may overcome such drawbacks in terms
of purity of the final product, ecological and economic constraints of the current catalysis processes
or extraction from plant material. In particular, the ability of oxidative enzymes (e.g., oxygenases)
to modify the monoterpene backbone, with high regio- and stereo-selectivity, is attractive for the
production of “natural” aromas for the flavor and fragrances industries. We review the research
efforts carried out in the molecular analysis of bacterial monoterpene catabolic pathways and bio-
chemical characterization of the respective key oxidative enzymes, with particular focus on the most
relevant precursors, β-pinene, limonene and β-myrcene. The presented overview of the current
state of art demonstrates that the specialized enzymatic repertoires of monoterpene-catabolizing
bacteria are expanding the toolbox towards the tailored and sustainable biotechnological production
of values-added aroma compounds (e.g., isonovalal, α-terpineol, and carvone isomers) whose imple-
mentation must be supported by the current advances in systems biology and metabolic engineering
approaches.
Keywords: plant volatiles; monoterpene biotransformation; valorization of plant material; microbial
cell factories; essential oils; β-pinene; limonene; β-myrcene
1. The Importance of Aroma Compounds in Industry
The utilization of flavor and fragrance compounds (hereby designated as aroma com-
pounds) is very well established in our current society, as such compounds are extensively
used in the food industry (e.g., beverages, processed food, ready-to-eat meals), agrochemi-
cals, household products (e.g., detergents, soaps), cosmetics (e.g., fine fragrances, toiletries
and body care commodities) and pharmaceuticals (e.g., dietary supplements and nutraceu-
ticals) [1]. The worldwide market for flavor and fragrance compounds was estimated to
reach a value of USD 28.2 billion in 2017 and is forecast to grow at a compound annual
growth rate of 5.3% up to 2023, driven by the increased demand for aroma compounds [2].
Aroma compounds are usually present in nature, mainly in plant organs, such as
leaves, flowers and fruits. Their isolation involves several extraction, fractionation and
purification processes (e.g., solvent extraction, distillation and chromatography) in order to
obtain an extract with a high degree of purity and low chemical complexity [2,3]. Due to the
limitations encountered in the current extraction methodologies from plant sources (e.g., not
enough yield to satisfy the commercial demand, production costs, seasonal availability of
plant raw material, risk of plant disease, variable composition of the plant extracts due
to biotic and abiotic factors and stability of the extracted compounds), they have been
preferentially obtained by chemical catalysis. Thus, from the market perspective, the latter
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synthetic compounds are most commonly used, since they are usually less expensive to
manufacture and have been thoroughly tested regarding their biosafety [4,5].
In order to improve the utilization of raw materials and the reduction of chemical
wastes in the manufacture and application of chemical products, the US Environmental
Protection Agency coined the term “Green Chemistry” in 1990 [6]. The initiative endorsed
efforts to improve or replace the conventional methodologies used in chemical synthesis,
according to new guidelines which envisaged a sustainable catalysis, such as (i) the pref-
erential utilization of renewable starting materials; (ii) the utilization of catalysts rather
than stoichiometric reagents, which in turn, increase the efficiency of the synthesis; (iii) the
utilization of nonhazardous and less toxic solvents; (iv) the design of shorter and more
energetically efficient synthesis protocols, with milder reaction conditions; and (v) the
strategical planning of the resulting reaction products and the procedures for their degra-
dation (reviewed in [6] and references therein).
In 1997, nearly 80% of the flavors and fragrances used world-wide were produced
by chemical synthesis, by multistep reactions in which the reagents were physically and
chemically manipulated in order to obtain the desired compound. In the last century, great
effort has been invested in the development of biological alternatives of aroma compounds,
and the emergence of new chromatographic technologies allowed the separation and
structural characterization of new natural molecules [7].
The trend towards the consumption of products labelled as “natural” or containing
“natural compounds” has been increasing, mainly driven by the growing concern to reduce
the ecological impact of the chemical industries and dependence on petroleum-based
starting materials and by the need to expand the chemical catalogue of the synthetic
approach [4,8]. This socioeconomic framework paved the way for the development of new
strategies for the production of fine chemicals, such as top-selling flavors and fragrances [9],
prompting the biotechnological exploitation of the microbial versatility to establish a
sustainable bio-based economy [4,8].
Additionally, the flavoring and fragrance regulations in Europe and USA have been
reviewed and adapted to encompass the scientific and technological advances in the
biotechnological production of aroma compounds. According to the European and the US
Code of Federal Regulations (e.g., EC 1334/2008, EC 872/2012, EC 1223/2009, US CFR
1990), compounds obtained by physical, enzymatic or microbiological processes, involving
precursors isolated from vegetable, animal or microbiological origin, may be classified as
“natural” [10,11].
The family of organic compounds applied in flavoring and fragrance industries in-
cludes alcohols, aldehydes, carboxylic acids, furans, fatty acids, esters, ethers, hydrocar-
bons, ketones, lactones, pyrazines and terpenes, with the latter representing the largest
category (Table 1) [5,12,13].
Table 1. Examples of the most relevant compounds currently used by the flavor and fragrance industries (based on the
information retrieved from the website of the companies, as well as from references [5,12,13].
Compound Aroma Observations of Biotech Production
Phenolic aldehydes
vanillin vanilla aroma
biotech production established by,
e.g., Evolva-IFF, Solvay, Mane, Shangai
Apple, BASF, Isobionics
safranal saffron aroma, sweet, spicy, floral odor with abitter taste
biotech production announced by,
e.g., Evolva
Lactones
γ-decalactone fruity, peach-like aroma biotech production established by,e.g., BASF, Symrise
γ-undecalactone fruity, sweat peach-like aroma -
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Table 1. Cont.
Compound Aroma Observations of Biotech Production
Ketones
2-heptanone fruity, cinnamon, banana-like -
α- and β-Ionone woody, raspberry-type, floral, violet-like odor -
nootkatone citrusy notes and grapefruit-like aroma
biotech production established by,
e.g., Allylix (Evolva), Isobionics,
Oxford Biotrans
Alcohols
1-octen-3-ol sweet, earthy, herbaceous floral notes, reminiscentof lavender -
Carboxylic acids
citric acid acid taste; odorless -
Esters
ethyl butanoate sweet and pineapple-like aroma -
Essential Oils
orange peel oil orange aroma -
lemon peel oil lemon aroma -
eucalyptus oil camphoraceous odor, spicy, cooling taste -
peppermint oil odor of peppermint, cooling, minty, menthol,sweet taste -
spearmint oil minty, carvone-like, cooling, candy, spicy -
Monoterpenes
α-pinene
terpy, citrus and spicy, woody pine and
turpentine-like with a slight cooling
camphoraceous nutmeg-like note
-
β-pinene cooling, woody, piney and turpentine-like with afresh minty, eucalyptus and camphoraceous note -
1,8-cineole cooling, fresh, oily, green, spicy, pine-like -
limonene
(+)-limonene has an orange-like odor
(−)-limonene has a more harsh turpentine-like
odor with a lemon note
-
(−)-menthol minty, coolant odor -
menthone minty, cooling, sweet, peppermint, camphoraceousaroma with a green herbal anise nuance -
carvone (R)-(−)-carvone has a spearmint aroma(S)-(+)-carvone has a caraway aroma -
α-terpineol pine odor, floral aroma -
β-myrcene terpy, herbaceous, woody odor with amango-like nuance. -
linalool floral, fresh, sweet, citrus-like aroma -
citronellol rose-like scent -
citral lemon, peely, citrus, floral with woody andcandy notes. -
geraniol rose-like, sweet, fruity aroma -
Sesquiterpenes
α-farnesene dry woody, green leafy, herbal and floral nuance biotech production established by,e.g., Amyris-Antibióticos S.A
(+)-valencene sweet, fresh, grapefruit-like aroma biotech production established by,e.g., Allylix (Evolva), Isobionics
Currently, several companies are investing in microbial biotechnology to establish the
production of commercial important “natural” aromas using microbial biotechnology, and,
in some cases, these aroma compounds are already commercialized (Table 1) [7,14–20]. The
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peach-flavored γ-decalactone was one of the first commercial aroma compounds obtained
by biotechnological processes, through the bioconversion of the triglyceride 12-hydroxy-9-
octadecene acid from castor seed (Ricinus communis L.) oil by Yarrowia lipolytica [20].
The establishment of the biotechnological production of vanillin is another successful
example of the increasing competitiveness of “natural” aroma. Vanillin is responsible
for the vanilla aroma, being one of the most popular aroma compounds (Table 1), with
an estimated annual demand of approximately 20,000 tons in 2014 [15]. The commercial
vanilla has been mainly produced by chemical catalysis from petroleum-derived phenol
(converted into guaiacol) and glyoxylic acid, since approximately 40,000 pollinated flowers
are required to collect around 500 kg of vanilla pods and extract 1 kg of vanillin [15,21].
In recent years, several companies produced vanillin from a broad range of precursors
(e.g., lignin, monoterpenes eugenol and isoeugenol from clove oil, phenolic stilbenes
and ferulic acid, which is a by-product of the production of rice bran oil) by patented
biotechnological processes mediated by microorganisms (e.g., bacterial strains of Escherichia
coli, Streptomyces spp. and Pseudomonas putida, as well as yeast strains of Schizosaccharomyces
pombe) [17].
Other examples of aroma compounds whose biotechnological production is well
established include nootkatone, trans-β-farnesene and (+)-valencene (Table 1). In particular,
the utilization of microbial biotechnology has become an attractive strategy to overcome
constrains of the chemical catalysis regarding very hydrophobic and volatile plant-derived
aroma compounds, such as essential oils and their monoterpenic fractions.
1.1. Scope of the Review
The present review is intended to present an overview of the current advances in the
production of monoterpene derivatives as fine chemicals, carried out by bacterial cells and
bacterial enzymes. Although this work does not include and extensive description of the
biological properties of the monoterpene derivatives generated in the reported bacterial
metabolisms (reviewed in [1] and references therein), we highlight the main monoterpene
catabolic pathways and bacterial strains currently characterized with molecular approaches
as potential source of novel enzymes and novel biomolecules. Major emphasis was placed
on the production of monoterpene derivatives with relevant biological activity for applica-
tion in flavoring and fragrances industries, as well as for the development of agrochemicals
and biocontrol agents.
The following search terms were used individually and in combination to retrieve
the majority of the available and published literature on monoterpene biotechnology by
bacteria: “monoterpene biotechnology”, “monoterpene biotransformation”, “monoterpene
biocatalysis”, “microbial catalysis terpene”, “pinene biotechnology”, “limonene biotechnol-
ogy”, “myrcene biotechnology”, “cytochrome terpene” and “cytochrome catalysis”. The
information retrieved was complemented and validated by using specific search terms to
target literature regarding the biotechnology of the most common monoterpene derivatives
(e.g., name of compounds included in Table 1) and the monoterpene-catabolizing bacterial
strains identified throughout the process. The literature surveys were performed using
Google Scholar and NCBI PubMed, mainly considering original research articles, as well
as review articles and the references therein. We believe that this approach provided a
comprehensive overview of the field. Nevertheless, a few articles may not have been
incorporated when the above search terms were not explicitly mentioned in keywords, title
or abstract.
1.2. Aroma Compounds in Nature: Monoterpenes and Monoterpenoids
Monoterpenes belong to one of the largest classes of plant secondary metabolites—
the terpenes—and are synthesized by the condensation of two molecules of C5 isoprene
(2-methyl-1,3-butadiene) into a C10 hydrocarbon backbone [22,23]. Monoterpenes and
their derivatives (monoterpenoids, resulting from oxygenation, methylation and esterifi-
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cation, among others) are volatile and highly hydrophobic compounds, predominantly
found in plant essential oils.
The variability of carbon backbones (e.g., length, cyclic versus acyclic molecular struc-
ture, and the existence of functional groups) is responsible for the functional diversification
of monoterpenes, which play different roles in the physiology of plants, such as in plant
defense against microbial, insect and herbivores attack, as well as in plant-to-plant com-
munication and pollinator attraction [22,23]. This functional diversity is responsible for
the broad range of organoleptic and therapeutic properties observed. Monoterpenoids are
usually less hydrophobic and less volatile than their monoterpene counterparts, whereas
the properties of the original molecule are retained or even enhanced [7,24]. Therefore,
monoterpenoids have great industrial relevance and allow a more stable incorporation
in aqueous formulations. As value-added compounds, monoterpenoids usually have a
higher market value (e.g., in 2017, de Oliveira Felipe et al. reported that (R)-(+)-limonene
presented a reference price of USD 34 L−1 whereas the market price of the derivatives
carveol, carvone and perillyl alcohol was USD 529 L−1, USD 350 L−1 and USD 405 L−1,
respectively [4].
Monoterpenes and monoterpenoids obtained from natural sources are considered as
GRAS (generally recognized as safe) compounds and can be added to products without
being considered as artificial additives. This status was given in 1965, being reviewed and
reaffirmed as GRAS in 2010, based on studies concerning the rapid absorption, metabolic
conversion and elimination in humans and animals, as well as in studies of subchronic
and chronic pathologies showing the lack of significant genotoxic and mutagenic potential,
thus without posing any significant risk to human health [25].
2. Catalysis Mediated by Biological Systems
The biological-based production of value-added compounds, either using whole
cells or purified enzymes, offers additional promising advantages when compared to
the chemical catalysis. The main advantages of microbial biotechnology over chemical
methods include (i) the ability to produce compounds, often with higher regio- and stereo-
selectivity, especially in enzyme-mediated catalysis (e.g., selective oxygenation of C=C
or C–H bonds in the hydrocarbon backbone); (ii) a higher reaction efficiency which is
translated in the requirement of smaller amounts of catalyst; (iii) the utilization of mild
reaction conditions of temperature and pH (usually ranging from 20 to 40 ◦C and from
pH values of 5 to 8), which minimizes undesired side reactions such as decomposition,
isomerization, racemization and rearrangements of the chemical species (reviewed in [6]
and references therein).
Moreover, different enzymes usually require compatible reaction conditions which
allow the setup of multienzyme systems for reaction cascades in order to simplify the cat-
alytic process. In some contexts, the utilization of microbial cells as catalysts might present
some advantages. Cells, as biofactories, provide an adequate environment and cofactors
for an optimal enzymatic stability and activity, especially when a multistep catalysis is
required. Additionally, different microbial cells/species can be used as communities, to
perform functions which would otherwise endow heavy metabolic burden for individual
cells (e.g., independent pathways competing for intracellular resources, and accumulation
of intermediates to high/toxic concentrations) [26]. The advantages of the whole cell-based
catalysis is also associated with the ease of microbial cultivation, speed of growth supported
by the use of less expensive substrates, which, in many cases, might be wastes/by-products
of other industrial processes, and the capability to be genetically altered [6,27].
The biotechnological production of monoterpenes and monoterpenoids as aroma com-
pounds may be accomplished by single-step biocatalysis and multistep biotransformation
of a precursor into a specific product or de novo synthesis from simple building block
molecules as carbon sources, which are converted into more complex biomolecules through
anabolic pathways [4,14,17]. At the first stage, the biological system, and particularly
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whole cells, must come into contact with the substrate and remain stable to catalyze the
transformations in the monoterpene backbone.
2.1. Bacterial Adaptation to the Hydrophobicity of Monoterpene Substrates
The hydrocarbon structure of monoterpenes and monoterpenoids provides them with
high hydrophobicity and, similarly to other membrane-active organic compounds like
alkanes, they are capable of easily altering the membrane fluidity (usually increasing it)
by accumulating within the acyl chains of phospholipids [28–30]. The cell membrane is
a permeability barrier against harmful compounds and acts as a matrix for proteins (sig-
naling, transport and enzymes) and energy transduction processes [31,32]. Consequently,
hydrophobic organic compounds may inactivate membrane-associated proteins (e.g., AT-
Pases and ion channels/pumps essential for energy and ion homeostasis), cause leakage of
ions and intracellular macromolecules due to changes in the permeability and integrity,
abolish membrane potential and even alter the proton gradient, which results in an altered
intracellular pH [28]. Ultimately, the loss of membrane function leads to impairment of cell
metabolism, inhibition of growth and cell death.
The toxicity derived from hydrophobic organic compounds is correlated with the
logarithm of its octanol/water partition coefficient (LogP or Log Kow), in which LogP
values ranging from 1 to 5 usually translate into compound toxicity for whole cells [28,31].
As an adaptive response, cells may change the membrane fatty acid profile to preserve
membrane characteristics. Nevertheless, the mechanisms reported seem to be dependent
on the genomic background of the cell and cell physiology (e.g., the growth phase), but
also on the chemical properties (e.g., acyclic vs. cyclic, chain length, branching degree,
and the degree and position of the oxyfunctionalization) and concentration of the stressor
([30,33–35] and references therein).
In general, facing an instant increase in the membrane fluidity and swelling due to
the partitioning and accumulation of organic compounds into the lipid bilayer, cells might
behave in the following ways:
I. They may increase the degree of saturation of fatty acids by de novo synthesis of
new molecules when cell growth is not inhibited. The increase in saturated acyl
chains leads to a denser membrane packing, thereby improving the tolerance towards
organic compounds [31,32].
II. They may alter the length of the acyl chains by increasing the synthesis of fatty acids
with longer acyl chains. Longer lipid molecules have higher melting temperatures;
therefore, the conversion of the membrane from a lamellar gel to liquid crystalline
phase is hindered [31,32].
III. They may alter the profile of phospholipid head groups, which is predicted to influ-
ence the physical and chemical properties of the membrane (e.g., charge and melting
point) [31].
IV. They may swiftly increase cell surface hydrophobicity by altering the composition of
the lipopolysaccharide layer (e.g., complete loss of B band lipopolysaccharide), and
generate outer membrane vesicles (OMVs). Although this ubiquitous mechanism has
not been extensively reported as a response to hydrophobic stress, several studies with
solvent-tolerant P. putida strains have shown the induction of vesiculation mediated
by alkanes and alkanols ([36] and references therein). This strategy may provide an
enhanced ability for protective cell attachment, aggregation and biofilm formation,
as well as for partitioning the hydrocarbon stressor in vesicles ([37] and references
therein).
V. Several bacterial strains (e.g., Pseudomonas spp., Vibrio spp., strains of Methylococcus
capsulatus, Alcanivorax borkumensis and Colwellia psychrerythraea) employ a fifth adap-
tive mechanism by isomerizing cis-unsaturated fatty acids to trans-unsaturated acyl
chains ([37] and references therein). Cis-unsaturated acyl chains comprise a bend of
30◦, which disturbs the ordered fatty acid packing, increasing fluidity, allowing denser
packing and promoting an increase in membrane stiffness to counteract excessive
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fluidity ([37] and references therein). This membrane cis-to-trans isomerization is
performed by cis/trans isomerases, and since it is dependent on neither energy nor on
the de novo synthesis of fatty acid molecules, this mechanism is considered a rapid
short-term response to chemical stress.
2.2. Mechanisms for the Bacterial Transformation of the Hydrocarbon Backbone
In bacteria, the biotransformation of monoterpenes and monoterpenoids is carried
out by similar mechanisms described for the catabolism of the medium-chain hydrocarbon
backbone (C5 to C12 chain) of n-alkenes and n-alkanes [38], which involves multiple
oxidative steps with the subsequent formation of alcohols, aldehydes/ketones and fatty
acid-like molecules activated with a coenzyme A moiety (CoA). The CoA derivatives are
then channeled into the central metabolism by a β-oxidation-like enzymatic machinery,
yielding a C2 acetyl-CoA molecule and a fatty acid with two less carbon atoms than the
original substrate [39] (Figure 1).
Molecules 2021, 26, x FOR PEER REVIEW 7 of 31 
 
 
V. Several bacterial strains (e.g., Pseudomonas spp., Vibrio spp., strains of Methylococcus 
capsulatus, Alcanivorax borkumensis and Colwellia psychrerythraea) employ a fifth adap-
tive mechanism by isomerizing cis-unsaturated fatty acids to trans-unsaturated acyl 
chains ([37] and references therein). Cis-unsaturated acyl chains comprise a bend of 
30°, which disturbs the ordered fatty acid packing, increasing fluidity, allowing 
denser packing and promoting an increase in membrane stiffness to counteract ex-
cessive fluidity ([37] and references therein). This membrane cis-to-trans isomeriza-
tion is performed by cis/trans isomerases, and since it is depe dent on neither energy 
nor on the de novo synthesis of fatty acid molecules, this mechanism is considered a 
rapid short-term respons  to chemical stress. 
2.2. echanisms for the Bacterial Transformation of the Hydrocarbon Backbone 
In bacteria, the biotransformation of monoterpenes and monoterpenoids is carried 
out by similar mechanisms described for the catabolism of the medium-chain hydrocar-
bon backbone (C5 to C12 chain) of n-alkenes and n-alkanes [38], which involves multiple 
oxidative steps ith the subsequent formation of alcohols, aldehydes/ketones and fatty acid-
like molecules activated with a coenzyme A moiety (CoA). The CoA derivatives are then chan-
neled into the central metabolism by a β-oxidation-like enzymatic machinery, yielding a C2 
acetyl-CoA molecule and a fatty acid with two less carbon atoms than the original substrate 
[39] (Figure 1). 
 
Figure 1. β-Oxidation pathway for the catabolism of coenzyme A moiety (CoA)-activated 
hydrocarbons in bacteria. After activation of the carboxyl group of the acyl chain (I), an 
acyl-CoA dehydrogenase catalyses the reduction of the bond between the α,β carbon 
atoms (A) to form an unsaturated derivative (II), which is further hydroxylated at the β-
carbon by a enoyl-CoA hydratase (B). The β-hydroxyl-derivative (III) is oxidized into a 
β-keto-derivative (IV) by a β-hydroxyacyl-CoA dehydrogenase (C) for subsequent re-
moval of a C2 moiety as acetyl-CoA (VI) by an acyl-CoA acetyltransferase/thiolase (D). 
The resulting acyl chain is thus shortened by two carbon atoms (V) and remains acti-
vated with a CoA moiety for another β-oxidation cycle. 
Figure 1. - xidation pathway for the cat bolism of coenzyme A moiety (CoA)-activated hy-
drocarbons in bacteria. After activation of the carboxyl gr up of the acyl chain (I), an acyl-CoA
dehydrogenase catalyses th reduction of the bond between the α,β carbon atoms (A) to form an
unsaturated derivative (II), which is further hydroxylated at t e β-carbon by a enoyl-CoA hydratase
(B). The β-hydroxyl-derivative (III) is oxidized into a β-keto-derivative (IV) by a β-hy roxyacyl-CoA
dehydrogenase (C) for subsequent rem val of a C2 moiety as acetyl-CoA (VI) by an acyl-CoA acetyl-
transferase/thiolase (D). The resulting acyl chain is thus sh rtened by two carbon atoms (V) and
remains activated with a CoA moiety f r another β-oxidation cycle.
Although the β-oxidation mechanism is common among bacteria, the strategies
adopted by hydrocarbon-catabolizing bacteria to initiate the catabolism of this type of car-
bon sources greatly differ among strains (Table 2), according to their genomic background
and physiology, the acyl chain length, degree of saturation and backbone branching or
cyclization (reviewed in [40,41] and references therein).
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Table 2. Biocatalysts currently used in industrial applications, derived from research of monoterpene catabolism in bacteria.
Whole-Cell Biocatalyst Substrate Product Ref.
Pseudomonas sp. TK2102 Eugenol vanillin [42](JP patent 5227980)
Pseudomonas putida ATCC55180 Eugenol
vanillin [43](US patent 5128253) Ferulic acid
Pseudomonas sp. NCIB 11671
α- and β-Pinene
(−)-carvone
(spearmint aroma) [44](US patent 4495284)































from Bacillus subtilis ECU0554 (±)-menthol esters (−)-menthol [47]
2.2.1. Molecular Mechanism for the Catabolism of the Unsaturated Hydrocarbon Backbone
The catabolism of acyclic or cyclic medium-chain unsaturated hydrocarbons starts
either with the formation of a hydroxyl group into a C–OH bound or by the epoxidation of
a double bond [41] (Figure 2). The first oxygenation of the nonpolar backbone is usually
the rate-limiting step in the catabolism of hydrocarbons.
Particularly, the aerobic catabolism of acyclic hydrocarbons might be initiated by
(i) terminal hydroxylation [41,48,49], (ii) hydroxylation at both termini (ω-oxidation) which
results in dioic backbones [41,50], (iii) sub-terminal oxidation into secondary alcohols
(α-oxidation) [40] or (iv) Finnerty oxidation mediated by a dioxygenase [51]. Moreover,
the epoxidation of an unsatured bound generates an epoxide ring, which might react with
cellular biomolecules (e.g., DNA and proteins; Figure 2). Therefore, the epoxide ring may
be further cleaved into an alcohol by several mechanisms that neutralizes its reactivity,
namely (i) by the activity of epoxide hydrolases (e.g., conversion of 3,4-epoxybutyrate by
an Acinetobacter baumannii strain [52] or conversion of limonene-1,2-epoxide to limonene-
1,2-diol by the Rhodococcus erythropolis DCL14 strain [53]); (ii) by the conjugation with the
thiol group of glutathione, mediated by the redox scavenging system of glutathione trans-
ferases [54] (e.g., catabolism of isoprene monoxide and aliphatic epoxides by Rhodococcus
sp.); or (iii) by the carboxylation of the epoxide bound with carbon dioxide to form a keto
acid (e.g., conversion of 2,3-epoxybutane by an epoxide carboxylase of the Xanthobacter sp.
Py2 strain [55]).
The catabolism of cyclic hydrocarbons in aerobic bacteria, such as the monoterpene-
related cyclohexane backbone, is initiated by sequential oxidations to form a cyclic ketone
(Figure 2). The following catabolic step is mediated by a Baeyer–Villiger monooxygenase,
which catalyzes the oxygen insertion into the cyclic ring and generates a caprolactone [56].
The ring is cleaved by a lactone hydrolase into an acyclic oxygenated compound, which
can be degraded by enzymatic systems acting on acyclic hydrocarbons [41].
The anaerobic degradation of unsaturated hydrocarbons mainly involves the hydra-
tion of the double bond to a saturated alcohol to allow catalysis by the n-alkane-degrading
enzymes (Figure 2) [57,58]. In anaerobic bacteria, two main mechanisms have been reported
for the catabolism of acyclic n-alkanes, which include the addition of a fumarate moiety
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(usually at the sub-terminal C2 atom) or a carboxyl moiety derived from bicarbonate to the
n-alkane backbone [57,59]. The catabolism of the cyclohexane backbone in the absence of
molecular oxygen has been proposed to include the generation of a ketone, whose ring is
cleaved by hydrolysis of the C–C bond [60].




Figure 2. Schematic overview of the catabolic pathways described for acyclic or cyclic medium-
chain unsaturated and branched hydrocarbon backbones in bacteria. The catabolism of the unsatu-
rated cyclic backbone is similar to the catabolism of saturated cyclic alkanes, once the molecule is 
oxidized into a ketone. After being converted to a n-alkane-like backbone, the hydrocarbon inter-
mediates are channeled to the central metabolism by β-oxidation-like pathways. Grey arrows de-
pict mechanisms described for anaerobic bacteria, and black arrows depict mechanisms described 
for aerobic bacteria. R1, R2 and R3 may represent hydrogen atoms or any hydrocarbon-related 
group. 
Particularly, the aerobic catabolism of acyclic hydrocarbons might be initiated by (i) 
terminal hydroxylation [41,48,49], (ii) hydroxylation at both termini (ω-oxidation) which 
results in dioic backbones [41,50], (iii) sub-terminal oxidation into secondary alcohols (α-
oxidation) [40] or (iv) Finnerty oxidation mediated by a dioxygenase [51]. Moreover, the 
epoxidation of an unsatured bound generates an epoxide ring, which might react with 
cellular biomolecules (e.g., DNA and proteins; Figure 2). Therefore, the epoxide ring may 
be further cleaved into an alcohol by several mechanisms that neutralizes its reactivity, 
namely (i) by the activity of epoxide hydrolases (e.g., conversion of 3,4-epoxybutyrate by 
an Acinetobacter baumannii strain [52] or conversion of limonene-1,2-epoxide to limonene-
1,2-diol by the Rhodococcus erythropolis DCL14 strain [53]); (ii) by the conjugation with the 
Figure 2. Schematic overview of the catabolic pathways described for acyclic or cyclic medium-chain
unsaturated and branched hydrocarbon backbones in bacteria. The catabolism of the unsaturated
cyclic backbone is similar to the catabolism of saturated cyclic alkanes, once the molecule is oxidized
into a k tone. After being converted t a n-alkane-like backbone, the hydrocarbon intermediates a e
channeled to the central metabolism by β-oxidation-like pathways. Grey arrows depict mechanisms
described for anaerobic bacteria, and black arrows depict mechanisms described for aerobic bacteria.
R1, R2 and R3 may represent hydrogen atoms or any hydrocarbon-related group.
2.2.2. Molecular Mechanism for the Catabolism of the Branched Hydrocarbon Backbone
As a result of isoprene condensation, monoterpenes have branched backbones. The
substitution of protons near the termini of an alkyl hydrocarbon chain, particularly in the
β-carbon (3-methyl branched) or a quaternary branch, is described to sterically hamper the
activity of the enzymes of the β-oxidation pathway [41,61]. Therefore, alternative strate-
gies are used by monoterpene-catabolizing microorganisms to mineralize the branched
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backbone (Figure 2). The 2-methyl branched hydrocarbons have been reported to undergo
terminal oxidation (e.g.,ω-oxidation) similarly to n-alkane substrates, yielding mono- or
di-carboxylic acids. The β-oxidation-like mechanism of this branched terminal is asso-
ciated with the release of a propionyl-CoA moiety, rather than the common acyl-CoA
molecule, which might be channeled to the central metabolism through the 2-methyl citrate
cycle [62]. In the catabolism of 3-methyl branched hydrocarbons, the carbon source back-
bone might undergo a β-decarboxylation to allow the degradation through the β-oxidation
pathway (Figure 2). The catabolism of geranic acid (3,7-dimethylocta-2,6-dienoic acid) by
the acyclic terpene utilization pathway has been the most well-characterized example of
this mechanism [62–64]. The geranic acid is converted to geranyl-CoA, and its β-methyl
group is converted to an acetate group by carboxylation, yielding isohexenyl-glutaconyl-
CoA [65]. After addition of a hydroxyl group to resolve the double bond in the C3 position
of isohexenyl-glutaconyl-CoA, an acetate moiety is released, and the β-oxidation of the
resulting 7-methyl-3-oxo-6-octenoyl-CoA molecule is resumed.
The anaerobic catabolism of 2-methyl branched hydrocarbons is proposed to occur via
similar mechanisms of the fumarate addition pathway for saturated backbones, followed
by decarboxylation and activation with a CoA moiety [66].
The monoterpene-catabolizing strains have evolved towards the mineralization of
this type of carbon source, and, thus, they may be considered promising biological systems
for monoterpene biotransformation, harboring specialized chemosensory and enzymatic
machinery for the oxidative catalysis of the monoterpene backbone, as well as being
capable of employing suitable physiological mechanisms to cope with and adapt to the
high hydrophobicity of these hydrocarbons.
2.3. Nature’s Reservoir of Bacterial Biocatalysts for Industrially Relevant Monoterpenes
This section reviews the reports of monoterpene catabolic pathways in bacteria
(Table S1 in the Supplementary Material), with particular focus on the biotransforma-
tion the main monoterpene precursors: the bicyclic α- and β-pinene, the cyclic limonene
and the acyclic β-myrcene.
2.3.1. Pinene Isomers: A Bicyclic Precursor
The pinene isomers (α- and β-pinene) are the most important monoterpenes in indus-
try. The α- and β-pinene represent 75% to 90% of the essential oil from conifers and can
be found in concentrations ranging from 50% to 70% and from 15% to 30%, respectively,
in turpentine oil (crude resin from conifer trees, especially pine trees), a by-product of the
paper and cellulose industry produced abundantly (e.g., worldwide production estimated
to reach 330,000 tons per year in 2013) [24,67]. Thus, α- and β-pinene are an inexpensive
and abundant monoterpene material. These compounds are the most abundant bicyclic
monoterpenes and can be precursors for derivation into virtually all monoterpenes used
in industrial applications, namely aroma compounds widely used in food and cosmetic
industries. The main derivatives directly obtained by chemical catalysis comprise borneol,
camphor, camphene, limonene, terpineols and terpinolene, carvone, verbenol, verbenone
and the acyclic β-myrcene (Figure 3) [68,69], which in turn can also be used as precursors
for the production of a broader array of molecules (see the following Sections 2.3.2 and
2.3.3 regarding limonene and β-myrcene, respectively).
Different pathways have been reported in the literature for the bacterial degradation
of pinene isomers (Figure 4).
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The epoxidation of α-pinene into α-pinene oxide was the first pathway proposed in
bacteria, mainly studied in Pseudomonas rhodesiae CIP 107491 and Sphingobium sp. NCIMB
11671 (former Pseudomonas fluorescens NCIMB 11671) strains. The ring cleavage of α-pinene
oxide, mediated by a putative α-pinene oxide lyase (the Prα-POL in CIP 107491 strain),
resulted in the formation of the aroma compounds isonovalal and novalal (Figure 4b,c) as
major biotransformation products in P. rhodesiae CIP 107491 and Sphingobium sp. NCIMB
11671, respectively [74,80]. The optimization of α-pinene oxide bi transformation in a n-
hex decane two-phase system, with sequential f edings of p rmeabilized CIP 107491 cells
and precursors, led to a maximum recover of 400 g L−1 of isonovalal [81]. Higher titers of
540 g L−1 of i novalal were further chieved with the constitutive he erologous expression
of Prα-POL in E. c li BL21(λDE3) in similar fed-batch biotra sform tion conditions, thereby
overc ming la ency p as s of preliminary indu tion nd endogenous regulatory pathways
in P. rh de ia CIP 107491 [82]. A s milar mech nism of ring cleavage was lso proposed in
the Nocardi sp. P18.3 train, although the epoxi e-forming α-pinene monooxyg nase was
never identified in any f the three str ins [75].
Savithiry et . ( 8) [70] reported the catabolism of α- and β-pi ne by the ther-
mophilic Bacillus pallidus BR425 strain, with the production of bi yclic and monocyclic
intermediates, via pinocarveol/myrtenol or limonene (Figure 4d–h). β-Pinene, pinocarveol,
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pinocarvone, myrtenol, myrtenal, limonene, and carveol were detected during the growth
of BR425 cells with an organic phase of α-pinene, which suggested a link between different
pathways and the ability of B. pallidus BR425 enzymatic repertoire to oxidized pinenes
at different positions [70] and generate diverse compounds with a broad application as
flavors, components of fragrances and of pharmaceuticals.
Industrially attractive monocyclic intermediates were also detected in biotransfor-
mation studies (Figure 4d–h) with the Pseudomonas sp. NCIMB 10684 strain (e.g., trans-
carveol) [73], a Serratia marcescens strain (e.g., trans-verbenol, verbenone, trans-sobrerol,
and α-terpineol) [79], the Pseudomonas sp. NCIMB 10687 strain (e.g., p-cymene, limonene,
α-terpinolene, α-terpineol, and borneol from both α- and β-pinene isomers) [76] and
Pseudomonas veronii ZW (e.g., p-cymene, limonene and myrtenol from α-pinene) [77].
2.3.2. Limonene: The Monocyclic Precursor
Limonene exists in nature as two enantiomers, (R)-(+)- and (S)-(−)-limonene, the
former being the most abundant isomeric form in plants. Although limonene can be
synthesized from pinene isomers, it is present in high concentrations in orange peel oil
(approximately 90%) and can be obtained in large amounts as by-product in the production
of citrus juice and pulps (e.g., worldwide production estimated to reach 30,000 tons per
year in 2013) [24,83,84]. The monocyclic structure of limonene is an inexpensive precursor
for the production of oxygenated derivatives, also with a broad range of applications due to
their odorant and bioactive properties: carveol, carvone isomers, perillyl alcohol, menthol,
p-cymene and α-terpineol, among others (Figure 3) [83,84].
In bacteria, there are four main alternative pathways described for the catabolism
of limonene (Figure 5). The most well-described model for limonene catabolism is the
R. erythropolis DCL14 strain (Figure 5a,b). R. erythropolis DCL14 is able to oxidize both
limonene enantiomers at the 1,2-double bond via the activity of a limonene-1,2-monooxyge-
nase LimB and limonene-1,2-epoxide hydrolase LimA, which results in limonene-1,2-
epoxide and limonene-1,2-diol, respectively, with 100% conversion yield [85,86]. The
aroma limonene-1,2-diol is hypothesized to be subsequently oxidized into the ketone
1-hydroxy-2-oxolimonene by a dehydrogenase and converted to a lactone by a Baeyer–
Villiger monooxygenase (1-hydroxy-2-oxolimonene 1,2-monooxygenase) for further ring
cleavage, activation with coenzyme A moiety and degradation by the β-oxidation-like
pathway. The generation of lactones is frequent in the bacterial catabolism of bicyclic
and monocyclic monoterpenes, catalyzed by Baeyer–Villiger monooxygenases (BVMOs).
These cyclic monoesters are present in all major classes of foods (e.g., fruits and vegeta-
bles, nuts, meat, milk products and baked products), in which they may contribute to
flavor nuances [87].
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The strain DCL14 can also degrade (R)- and (S)-limon ne through a second path-
way, in which the substrate is hydroxy ated in the 6-position by a putative limonene-6-
monooxyg nase nd generates (R)- and (S)-carveol. DCL14 c lls can oxidize both (R)-
and (S)-stereoisom rs to carvone nd dihydrocarvone, mediated by the carveol dehy-
drogenase LimC and a putative carvone reductase, respectively [97]. Although the con-
version of carveol isomers to flavoring carvone isomers has previously been detected in
other Gram-positive strains [70,98], the putative enzymes catalyzing the reaction have
never been characterized. In R. erythropolis DCL14, the monocyclic structure of (iso-
)dihydrocarvone isomers, may then be cleaved through a similar mechanisms acting on
1-hydroxy-2-oxolimonene: oxygenation by a BVMO into a lactone and subsequent lactone
hydrolysis to generate 6-hydroxy-3-isopropenylheptanoate or 6-hydroxy-5-isopropenyl-2-
methylhexanoate from (1R,4R)- or (1S,4R)-(iso-)dihydrocarvone, respectively [97]. Notably,
this ring-opening step is mediated by the monoterpene E-lactone hydrolase MlhB, which
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displays a broad substrate range for lactones derived not only from the biotransformation
of carvone, but also from isopulegol and menthol/menthone, among others [99]. The
extent of limonene biotransformation by DCL14 cells via limonene-6-monooxygenase
(the carveol/carvone-forming pathway) was reported to be dependent on the cytotoxicity
threshold of the accumulated carveol and carvone. Morrish and co-workers [100] were able
to enhance the product titers in a fed-batch two-phase partitioning bioreactor with silicone
oil, which allowed them to achieve up to 0.32 g L−1 of carvone by increasing the amount
of (+)-limonene used as C-source and of (−)-carveol used as substrate for the enzymatic
conversion.
Limonene biotransformation can also occur via hydroxylation of the primary methyl
group (in the C7 position) into the aroma perillyl alcohol [101] (Figure 5c), whose avail-
ability in nature is limited. Given the anticarcinogenic property of perillyl alcohol and
its derivative perillic acid, this pathway has been studied in members of several bacte-
rial genera, mainly aiming at the characterization of promising biocatalysts. The path-
way was initially described in Geobacillus stearothermophilus BR388 (former member of
Bacillus genus) [90], and the following research studies were focused on the optimization
of the hydroxylation with heterologous cytochrome CYP153A6 system from Mycobacterium
sp. HXN-1500 in P. putida and E. coli strains, as well as in Castellaniella defragrans DSM
12143 [89,92,102,103]. The genome sequencing, protein and metabolite profiling coupled to
mass spectrometry, as well as transposon mutagenesis approaches, located the key genes of
the anaerobic metabolism of cyclic monoterpenes from C. defragrans DSM 12143 in a 70 kb
locus, including four genes coding for a putative limonene dehydrogenase system: the
dehydrogenase subunits CtmA and CtmB, the ferredoxin CmtE and ferredoxin reductase
CmtF [89]. The highest titer of perillic acid was reported in P. putida DSM 12264 [92,104],
whose cultures produced up to 31 g L−1 after 7 days in a fed-batch bioreactor, by cou-
pling the biotransformation process with an in situ product recovery step based on anion
exchange resin to overcome perillic acid-mediated cellular inhibition.
Bacterial enzymatic machinery can also hydrate the limonene isoprenyl double bond
(in the C8 position) into the versatile α-terpineol [105] (Figure 5f). The highest titers of
biotechnologically produced α-terpineol have been reported in biotransformation exper-
iments with the bacteria Sphingobium sp. NCIMB 11671 by using two-phase bioreactor
systems. After optimizing pH, biocatalyst concentration, substrate concentration, the
aqueous:organic ratio, pH, temperature and agitation, approximately 240 g of (R)-(+)-α-
terpineol was produced per liter of sunflower oil organic phase from (R)-(+)-limonene,
with a 94.5% transformation yield [95,106].
Although α-terpineol seemed to be a dead-end product in Sphingobium sp. NCIMB
11671 and other limonene-transforming strains, the hydroxylation of α-terpineol to 7-
hydroxyterpineol was observed in an unclassified strain of the Pseudomonas genera, cat-
alyzed by the cytochrome CYP108A1 system (P450terp) [107,108].
In some bacterial strains, products not corresponding to the previous described path-
ways were reported: Production of the flavor compounds γ-valerolactone and cryptone,
linalool and dihydrolinalool, (Figure 5d,g) by the Kosakonia cowanii 6L strain (former mem-
ber of the Enterobacter genus) [91]; the epoxidation of the 8,9-double bond of limonene into
limonene-8,9-epoxide, a volatile found in mandarin and ginger, by the cyclohexane-grown
Xanthobacter sp. C20 strain (Figure 5e) [94]; and the production of sobrerol by the P. putida
MTCC 1072 strain [93], among others (Figure 5g).
2.3.3. β-Myrcene: The Versatile Acyclic Precursor
Currently, β-myrcene is mainly obtained from the pyrolysis of β-pinene [68]. The
acyclic and unsaturated structure of β-myrcene (e.g., 1,3-diene moiety) can undergo a
number of reactions, such as isomerization and cyclization, and, therefore, it is used as
a precursor for the production of many monoterpene derivatives [68], cyclic or acyclic,
unsaturated or saturated, and with diverse functional groups (Figure 3).
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An overview of the main reported pathways for the bacterial catabolism of β-myrcene
and other acyclic monoterpenoids is presented in Figure 6.
The first studies focused on the bacterial catabolism ofβ-myrcene involved the P. putida
S4-2 [109] and Pseudomonas sp. M1 strains [110]. Cultures of P. putida S4-2 initiated the
mineralization of β-myrcene by hydroxylation of the terminal C8-position, yielding (E)-
myrcen-8-ol (Figure 6a), with subsequent production of the (E)-2-methyl-6-methylene-
2,7-octadienoic acid (myrcenoic acid), 4-methylene-5-hexenoic acid and (E)-4-methyl-3-
hexenoic acid [109].
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corresponded to the following literature: (a) reported by [30,109]; (b) reported by [111]; (c) reported
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Iurescia and co-workers [110] reported the first molecular insights regarding the
genetic code underlying the β-myrcene catabolism via terminal hydroxylation as a re-
sult of the isolation of a Pseudomonas sp. M1 mutant (strain M1–N22) generated by Tn5
random mutagenesis. In strain M1–N22, the Tn5 transposon interrupted the alcohol
dehydrogenase-coding gene myrB, and impaired growth using β-myrcene as sole carbon
and energy sources, leading to the accumulation of (E)-myrcen-8-ol as the major β-myrcene
derivative during biotransformation experiments. The myr + wt phenotype of strain M1–
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N22 was restored by genetic complementation in a screening carried out with a M1-derived
genomic library, which led to the identification of four genes, organized as the cluster
myrDABC, potentially coding for β-myrcene-biotransforming enzymes. Based on the work
of Iurescia et al. and of Narushima et al. [109,110], the first catabolic pathway present in
both Pseudomonas strains was proposed to be initiated by the hydroxylation of β-myrcene
in the terminal carbon into myrcen-8-ol, followed by the oxidation to aldehyde by the
alcohol dehydrogenase MyrB, subsequent oxidation to the carboxylic acid by the putative
aldehyde dehydrogenase MyrA and activation by a coenzyme A moiety, involving the
putatives acyl-CoA synthetase MyrC and enoyl-CoA hydratase MyrD, which would allow
the channeling of β-myrcene intermediates to the central metabolism by an enzymatic
cascade analogous to the beta-oxidation pathway.
In the last decade, Pseudomonas sp. M1 has been characterized using a systems biology
approach at the genome, transcriptome and proteome levels in the scope of its outstanding
ability to mineralize β-myrcene [120,121]. The characterization of the β-myrcene stimulon
by RNA-seq identified a novel 28 kb genomic island (GI), not previously reported in any
other biological system, whose expression was strongly stimulated in the presence of β-
myrcene [121]. Consequently, the molecular characterization of the gene products coded by
the 28 kb GI suggested their putative involvement in the following: (i) monoterpene sensing;
(ii) regulation of gene expression; and (iii) β-myrcene oxidation and bioconversion of β-
myrcene derivatives into central metabolism intermediates [121], including the previously
identified myrDABC cluster [110].
Soares-Castro et al. carried out a metabolic footprint analysis of cultures of strain M1
wt supplemented with β-myrcene over time, and they detected (E)-myrcen-8-ol, myrcene
aldehyde and the myrcenoic acid at 30 min of β-myrcene biotransformation [30], thus sup-
porting the previously proposed β-myrcene catabolic pathway. Two putative derivatives
of the myrcenoic acid were detected in strain M1 wt supernatants after 3.5 h of β-myrcene
supplementation: (E)-4-methyl-3-hexenoic acid and the 4-methylhexanoic acid [30]. The
former was suggested by Narushima et al. [109] as a product of a β-oxidation-like catabolic
step targeting the myrcenoic acid with subsequent elimination of the carboxyl-containing
C3-unit as propionyl-CoA, whereas the latter might result from the dehydrogenation of
the C3,C4 double bond of (E)-4-methyl-3-hexenoic acid. From the set of β-myrcene deriva-
tives produced by strain M1, myrcen-8-ol and 4-methylhexanoic acid have been reported
to be insect pheromones and may be exploited as biocontrol agents [122,123], whereas
4-methyl-3-hexenoic acid is a described fragrance compound [124].
Moreover, the molecular and metabolic characterization of the myr- strains M1–C19
and M1–C38, obtained by Tn5 transposon mutagenesis to abolish the β-myrcene-inducible
expression of the β-myrcene core code, led to the identification of two gene products
essential to induce the 28 kb-encoded β-myrcene catabolic machinery and confer the
ability to use this monoterpene as sole carbon source in M1 cells [30]: (i) the LuxR family
transcriptional regulator MyrR (PM1_0322860), homologous to members of the MalT
subfamily and which may act as a sensory switch-like modulator of β-myrcene-inducible
gene expression; (ii) the membrane β-myrcene hydroxylase MyrH (PM1_0322855), which
is involved in the conversion of β-myrcene to myrcen-8-ol. Strikingly, the expression
of the GI modules also resulted in the successful biotransformation of other cyclic and
acyclic terpene backbones, originating oxidized metabolites, some of which with great
biotechnological potential. M1 cells biotransformed (−)-β-pinene into α-terpineol and
citronellic acid, whereas the cyclic structure of (R)-(+)-limonene was hydroxylated into
limonene-1,2-diol. Linalyl acetate and β-linalool were biotransformed into geraniol and
geranic acid, suggesting a common catabolic pathway with β-citronellol via the acyclic
terpene utilization pathway encoded in the M1 genome and extensively characterized in
Pseudomonas citronellolis DSM 50332 and Pseudomonas aeruginosa PA01 [65,118].
Esmaeli and Hashemi (2011) described the conversion of β-myrcene in the P. aerugi-
nosa PTCC 1074 strain, which produced dihydrolinalool, 2,6-dimethyloctane and the cyclic
α-terpineol [111] (Figure 6b). The overlapping degradation of β-myrcene with the catabolic
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pathways of other acyclic alcohols (linalool, geraniol) has also been described [64,112,125]
(Figure 6c,d). The anaerobe C. defragrans DSM 12143 codes a linalool dehydratase–isomerase
[58,125], which can catalyze the reversible hydration of β-myrcene to (S)-(+)-linalool and
isomerization of (S)-(+)-linalool to geraniol, apparently dependent on the equilibrium of
hydrocarbon-to-alcohol concentrations. Geraniol is further oxidized to geranic acid by
two identified geraniol and geranial dehydrogenases, GeoA and GeoB, respectively [58].
A similar isomerization mechanism of linalool to geraniol, followed by subsequent oxida-
tion to geranial and geranic acid, was proposed for the anaerobe Thauera linaloolentis DSM
12138 [64]. Geraniol was also detected in cultures of R. erythropolis MLT1 supplemented
with β-myrcene as the sole carbon source, although the enzyme involved in β-myrcene
oxygenation was not identified [112].
The production of important aroma compounds were also reported in the catabolism
of linalool, β-citronellol and geraniol by other bacterial strains, such as P. putida ATCC
29607, the cytochrome-rich Novosphingobium aromaticivorans DSM12444 and the menthol-
producing Pseudomonas convexa (Figure 6j) [114,115,117,119].
From the biotechnological perspective, once a particular pathway for monoterpene
biotransformation is identified and characterized, the next step involves the establishment
of the necessary knowledge to develop a metabolic engineering approach of such pathway
in a way that the biotransformation, rather than a complete mineralization, becomes
optimized and tailored for specific applications [69].
3. Exploiting the Biotechnological Potential of Monoterpene-Catabolizing Enzymes
The majority of monoterpene derivatives with industrial relevance has been detected
as metabolic intermediates in the reported catabolic pathways (presented in the Section 2),
suggesting that the repertoire of enzymes available in the environment is able to mimic
the current chemical synthesis reactions. A few biological systems are already used as
monoterpene biocatalysts (whole cells and individual enzymes) in industrial processes,
mainly focused on the production of the aroma compounds vanillin, carvone and (−)-
menthol (Table 2).
The literature revision presented in Section 2 also highlighted several other functional
modules that have been the focus of molecular and biochemical characterization, with
potential for the development of biotechnological tools (Table S2 in the Supplementary
Material).
The biochemical and structural characterization of enzymes from monoterpene-
catabolizing bacteria have been providing the necessary knowledge required for protein
engineering. In order to achieve an efficient and economically feasible biotechnological
process, protein optimization envisages the improvement of the catalytic productivity,
broadening pH and temperature range for enzyme activity, enhancement of substrate
selectivity, enhancement of protein solubility and long-term stability, changing regio- or
stereo-specificity and changing cofactor requirements [126,127]. Enzyme engineering can
also focus on altering cofactor dependence, reduce catalytic inhibition derived from ac-
cumulation of end-products and even expand the substrate range to other natural or
non-natural molecules [128,129]. This optimization can be performed by evolutionary ap-
proaches; rational protein design by directed mutagenesis towards key residues or domains;
de novo generation of enzymes based on computational algorithm; in silico modelling; and
creating chimeric proteins or utilizing protein, DNA or RNA scaffolds [130–132].
The cytochrome P450cam (CYP101A1) of P. putida ATCC 17453 and P. putida ATCC
29607, involved in the hydroxylation of camphor to 5-exo-hydroxycamphor (Table S2 in the
Supplementary Material), is one of the most extensively studied members of the cytochrome
family, being an archetypal model for structural and mechanistic studies. Several engineer-
ing strategies were carried out to modulate the substrate range of P450cam to non-native
compounds by substitution of key amino acid residues (e.g., the mutation Y96F translates
into a variant that better accommodates nonpolar monoterpenes in the active site) [133].
Some engineered variants of P450cam were able to oxidize other monoterpenes (e.g., α-and
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β-pinene, (+)-carene and 1,8-cineole (S)-limonene, among others) [133,134], polycyclic aro-
matic hydrocarbons (e.g., naphthalene, pyrene, phenanthrene and fluoranthene) [135,136],
polychlorinated benzenes [136], and even aliphatic gaseous alkanes (ethane, propane and
n-butane) [134,137]. Similarly, the directed evolution of the cytochrome P450BM-3 (fatty
acid hydroxylase CYP102A1) of Bacillus megaterium ATCC 14581 allowed the generation of
variants with altered substrate specificity towards the hydroxylation of different monoter-
penes (Table S2 in the Supplementary Material), including the differential conversion
of α-pinene into α-pinene oxide, the insect pheromones trans-verbenol and verbenone,
myrtenol and sobrerol, the oxidation of (R)-limonene into (R)-limonene-8,9-epoxide (pre-
viously detected in the biotransformation with Xanthobacter sp. C20) or perillyl alcohol
and the epoxidation of geraniol into 6,7-epoxygeraniol (a precursor of furanoids used in
fragrances) [132,133,138,139].
Several other cytochromes have been characterized throughout the year, in different
bacterial genera, showing that members of the class I of bacterial P450 cytochromes are
often highly active and selective, making them suitable for the oxyfunctionalization of the
monoterpene backbone. The engineering approaches carried out on bacterial cytochromes
has greatly benefit from the increasing knowledge generated on P450 cytochrome biochem-
istry and crystallography, including studies on other well characterized members involved
in monoterpene catabolism, such as the P450terp (CYP108A1) and P450cin (CYP176A1) of
Citrobacter braakii, and the P450lin (CYP111A1) of P. putida ATCC 29607, among others (Table
S2 in the Supplementary Material) [107,132,133,140]. Currently, the members of class I P450
cytochromes and their variants comprise one of the most well characterized toolbox for
bacterial biotechnology.
Another example is the characterization effort that has been carried out with the
limonene-1,2-epoxide hydrolase from the R. erythropolis DCL14 strain, which is structurally
different from other members of the same class, thereby translating into an epoxide-
cleaving mechanism with different stereoselectivity [141]. Besides limonene-1,2-epoxide,
limonene-1,2-epoxide hydrolase was able to transform other substrates, including cyclic
(e.g., 1-methylcyclohexene oxide, cyclohexene oxide and styrene-7,8-oxide) and aliphatic
backbones (e.g., 2-methyl-1,2-epoxides) [141,142], albeit showing lower activity levels.
Engineered variants of the cofactor-independent linalool dehydratase–isomerase Ldi of
C. defragrans DSM 12143 have been explored for the enzymatic dehydration of short-
chain alkanols into volatile dienes, such as butadiene and isoprene [143]. These studies
highlight the potential versatility and substrate modulation of such enzymes, aiming at the
production of unprecedented compounds and development of new catalytic processes.
Cyclic products have been detected as a result of the catabolism of some acyclic
monoterpenes, such as of β-myrcene, citronellol and linalool [111,117,119,144]. The bac-
terial monoterpene cyclases, which mimic the cyclization reactions performed in organic
chemistry and plant synthesis, also comprise an attractive class of enzymes for biocataly-
sis [145,146]. Although this class of enzymes appears to be annotated in several microbial
genomes, very little is known about their molecular and biochemical mechanisms in
bacterial, particularly in regard to using the monoterpene backbone as substrate for the
production of important cyclic aroma compounds, such as menthol and carvone. Bastian
et al. (2017) generated engineered variants of the squalene hopene cyclase from Alicy-
clobacillus acidocaldarius (AacSHC), which was able to catalyze the selective cyclization of
(S)-citronellal and (R)-citronellal to the different stereoisomers of isopulegol, including
(−)-iso-isopulegol, which is a key precursor for the production of the aroma compound
(−)-menthol [146].
3.1. Metagenomics Approaches May Expand the Bacterial Toolbox for the Production of
Monoterpene-Based Aroma Compounds
Bioprospection studies may be considered a key approach to isolate new strains
that convert substrates not yet explore by the current flavor and fragrances biotechnol-
ogy. Consequently, the modern biotechnology of monoterpenes must complement the
cultivation-dependent screening used as the gold standard with functional mining of
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metagenomes to access the unlimited potential of the environmental pool of enzymes and
monoterpene-catabolic pathways [147]. The first reports of a metagenome-based screening
to identify genes coding for monoterpene-catabolizing enzymes targeted the microbiome
of phytoparasites, which feed on a terpene-rich diet. The metagenome-based analysis
of the microbiome from the pinewood nematode Bursaphlenchus xylophilus [148] allowed
the identification of genes putatively involved in the catabolism of α-pinene, limonene
and geraniol, associated with the genera Pseudomonas, Achromobacter, and Agrobacterium.
Similarly, the microbiome of bark beetles has also been reported to comprise monoterpene-
metabolizing bacteria [149], from which five detected genes showed homology to α-pinene
catabolic enzymes (aldehyde dehydrogenase, an oxidoreductase, an enoyl-CoA hydratase
and two hydratases/epimerases) and were associated with the genera Pseudomonas, Rah-
nella, Serratia and Stenotrophomonas [149]. In 2014, the meta-transcriptome of the resin-
tolerant microbial community associated with pine tree galls, formed by the moth Retinia
resinella, detected expression of genes associated with α-pinene catabolism and the atu
pathway [150], widespread in more than 40 bacterial genera, from which Pseudomonas was
the most abundant genus.
Although functional characterization is required to assess the catalytic novelty of
these genes, which are identified based on homology search against limited databases of
monoterpene-catabolizing enzymes, the metagenomics studies are extending the taxonomic
knowledge regarding potential biocatalysts.
3.2. Holistic Approaches Are the Framework for Monoterpene Biocatalysis À La Carte
The current research has created a catalogue of relevant genes, proteins, pathways
and microorganisms, which hold great potential for monoterpene biotechnology and have
broadened the biotransformation prospects for virtually unlimited backbone modifications.
Nevertheless, despite the efforts to describe the biotransformation of monoterpenes and
monoterpenoids in different strains, the majority of the studies lack a holistic character-
ization of the catabolic pathways and of the monoterpene-catabolizing microorganisms
towards proper biotechnological exploitation.
Functional approaches based on high-throughput methodologies (e.g., transcriptomics,
proteomics, metabolomics, phenomics and epigenomics) are thus required to characterize
and quantify the dynamics underlying the biological processes and molecular interactions
of the biological components involved in the biotransformation of a monoterpene substrate.
Particularly, the comprehensive understanding of a studied microorganism as a potential
cell factory depends on an integrated genotype-to-phenotype overview describing the
biological system in order to enable the knowledge base to develop computational and
mathematical models, which are essential to predict the dynamic cell behavior and to
set the framework for the rational design of metabolic engineering strategies (reviewed
in [151] and references therein).
Moreover, a bacterial strain with potential to be used as a cell factory must be easily
cultivated under laboratory batch conditions and at a large production scale; grow quickly
with minimal nutritional requirements, especially when using low-cost feedstocks to
reduce production costs (e.g., monoterpene-rich industrial by-products); and present some
degree of solvent tolerance to cope with the hydrophobicity of the monoterpene backbone
(referred in Section 2.1 with more detail). The candidate strains must also be prone to
genetic manipulation. Although E. coli strains are the common workhorse for recombinant
approaches due to the well-established knowledge regarding their genetics, metabolism
and physiology, the advances of high-throughput approaches and synthetic biology-guided
genetic engineering tools have established strains of the genera Bacillus, Pseudomonas,
Rhodococcus and Corynebacterium, among others, as model organisms [151]. In particular,
industrially established strains for the production of biobased chemicals, certified as host–
vector systems (e.g., P. putida KT2440), may be regarded as promising hosts for the creation
of specialized aroma biocatalysts with heterologous functional models [152].
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The current metabolic engineering toolbox includes several platforms which allow
virtually any kind of genetic manipulation. Genome-wide engineering approaches usually
aim at the creation of strains with increased genome stability and reduced metabolic burden
by deletion of nonessential genes and mobile genomic loci. The approaches for targeted
genetic engineering may include the utilization of standardized vectors for recombinant
approaches and controlled protein expression (e.g., pSEVA architecture), biosensor modules
for live monitoring of the cell physiology and biotransformation performance, as well as the
targeted genetic manipulation or modulation of gene expression (e.g., CRISPR/Cas9-based
approaches) [151].
C. defragrans DSM 12143, N. aromaticivorans DSM 12444, P. aeruginosa PA01, P. citronellolis
DSM 50332, Pseudomonas fragi NBRC 3458, Pseudomonas protegens Pf-5, P. putida F1, Pseu-
domonas sp. M1, Sphingobium yanoikuyae B2 and T. linaloolentis DSM 12138 are the monoterpe-
ne-catabolizing strains whose genome was sequenced and is available for further molecular
and functional studies. In particular, the β-myrcene catabolic pathway of Pseudomonas
sp. M1 is one of the most well characterized cases in the literature. Preliminary work
carried out by Soares-Castro et al. [30,144] showed that the different genotypes of the
mutant strains M1-N2, M1-C19 and M1-C38 resulted in different metabolic profiles of
β-myrcene derivatives, including the differential production of the alcohols ipsdienol,
isomyrcenol and p-mentha-1,5-dien-8-ol, reported for their odorant and attractant/repellent
properties towards several insect species, which could be explored as potential biocontrol
agents [153,154]. Therefore, further characterization of these strains may set the adequate
knowledge ground to tune the functional modules of the 28-kb genomic island as ver-
satile catalytic tools. Furthermore, a holistic approach would greatly contribute to the
development of biotechnological tools towards the bulk production of (i) α-pinene deriva-
tives, such as isonovalal, with P. rhodesiae CIP 107491 enzymatic machinery; (ii) a broad
array of limonene derivatives using R. erythropolis DCL14 enzymes and (iii) α-terpineol by
Sphingobium sp. NCIMB 11671 enzymatic machinery.
The resilience and biotransformation performance of bacterial cells may be enhanced
by complementing the bioprocess with “in situ product removal” (ISPR) approaches
(reviewed in [155] and references therein), which allow one to enhance the volumetric
productivity and production yield, maintain the chemical stability of monoterpenes and
monoterpenoids (e.g., epoxides may be unstable in aqueous phases), reduce biocatalyst
inhibition mediated by the accumulation of the product, and decrease downstream process-
ing costs and the amount of waste water generated in the process. One of the most common
strategies consists of performing the biotransformation in a two-phase liquid system with
an organic top layer of a biocompatible solvent (e.g., n-dodecane, n-hexadecane, 1-octanol
and 1-decanol), which acts as a reservoir for monoterpenes and monoterpenoids that can be
recovered by distillation-based methodologies [155]. Two-phase liquid systems have been
applied in several studies of monoterpene biotransformation (as exemplified in several
case reports in Section 2.3), mainly in fed-batch bioreactor settings, in which higher yields
of production were usually obtained, also allowing the utilization of higher amounts of
substrate. Furthermore, the in situ removal of more hydrophilic products may be achieved
by recirculating the aqueous phase through an adsorbent matrix (e.g., affinity chromato-
graphic resin) [92,156]. Other complementary approaches for optimal ISPR must include
online monitoring of chemometric parameters and the mathematical modelling of the
downstream product recovery towards the development of a knowledge-base-controlled
process.
3.3. Coupling the Bacterial Synthesis of Monoterpene Precursors with the Oxidative Biocatalysis
into Aroma Compounds
As an alternative strategy, several studies have been focused on the de novo biosynthe-
sis of monoterpene precursors via anabolic pathways [14,157,158]. Monoterpenes can be
synthesized de novo from isopentenyl pyrophosphate and dimethylallyl pyrophosphate,
obtained by mevalonate (MVA) or 2-C-methyl-D-erythritol 4-phosphate (MEP) pathways,
using glucose or glycerol as precursors [159]. The isoprenoid synthesis is mediated by a
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geranyl pyrophosphate synthase (GPPS), coupled with specific monoterpene synthases
for the customized production of the desired monoterpene backbone (Table S3 in the Sup-
plementary Material). The genes used to assembly the biosynthetic pathways in bacterial
hosts are usually cloned from various sources, including yeast and plants, which were
reported to have often required a codon optimization step, for efficient translation in the
host organism.
The biosynthetic strategy with recombinant E. coli hosts has been applied for the pro-
duction of several bicyclic, cyclic and acyclic monoterpenes (Table S3 in the Supplementary
Material), such as α-pinene (up to 0.97 g L−1 [160]), β-pinene (up to 20 mg L−1 [161]),
cis-sabinene (reaching a maximum concentration of 2.7 g L−1 [162]), limonene (up to
2.7 g L−1 in a diisononylphthalate two-phase fed-batch setup [163]), β-myrcene (58 mg L−1
in a dodecane two-phase system [164]) and geraniol (0.18 g L−1 in a decane two-phase
system [165]).
Due to the well-studied tolerance of Pseudomonas spp. to hydrophobic compounds,
Mi and co-workers [166] produced geranic acid in a recombinant P. putida DSM 12264
by expression the MVA pathway and a geraniol synthase from Ocimum basilicum L. The
geraniol produced by the heterologous expression of the geraniol synthase was converted
to geranic acid by the enzymatic repertoire of the host. The utilization of glycerol as a
precursor led to the production of 0.19 g L−1 of geranic acid under fed-batch conditions
(Table S3 in the Supplementary Material).
Recombinant cyanobacteria (e.g., Synechococcus spp.) have also been studied as hosts
for the biosynthetic strategy (Table S3 in the Supplementary Material). These biological
systems utilize pyruvate and glyceraldehyde-3-phosphate produced by photosynthesis as
precursors for the native MEP pathway [167]. To date, published works on monoterpene
biosynthesis by recombinant cyanobacteria reported the production of low limonene titers
of up to 4 mg L−1 [167].
In a biotransformation-driven framework, the bacterial biosynthesis of monoter-
pene precursors in recombinant hosts may be promising if coupled to the expression
of monoterpene-transforming enzymes, either in the same host, in a mixed culture of
strains expressing different enzymatic modules or even in a synthetic biochemistry system.
To the best of our knowledge, very few studies have reported such a combined approach.
Alonso-Gutierrez et al. [168] coupled the synthesis of limonene via the MVA pathway and
activity of a limonene synthase from Abies grandis Lindl. in a recombinant E. coli DH1, with
the heterologous expression of the cytochrome CYP153A6 system (the P450 oxygenase,
the ferredoxin and the ferredoxin reductase subunits) of Mycobacterium sp. HXN-1500.
After several process optimizations (gene codon optimization, CYP153A6 induction dy-
namics and downstream perillyl alcohol recovery) to improve enzymatic availability and
activity, up to 0.44 g L−1 of L-limonene was endogenously produced from glucose, and
the perillyl alcohol titers, generated from the P450-mediated hydroxylation of L-limonene,
reached 0.11 g L−1.
Another promising approach relies on the utilization of a cell-free synthetic bio-
chemistry platform by mixing crude preparations or purified enzymes together into self-
sustainable metabolic pathways in vitro (Table S3 in the Supplementary Material). By
building a biochemistry platform harboring Embden–Meyerhof–Parnas glycolytic and
mevalonate enzymes, a system capable of recycling redox equivalents, as well as the α-
pinene synthase of Picea sitchensis (Bong.) Carr.) or limonene synthase of Mentha spicata
L. (wt or the mutant N345A), Korman et al. [158] were able to obtain higher titers for the
production of pinenes isomers (14.9 g L−1), limonene (12.5 g L−1) and sabinene (15.9 g L−1),
respectively, with >90% yield using 500 mM of glucose as a precursor. A similar rationale
could thus be applied for the tailored oxyfunctionalization of these monoterpenes into
value-added derivatives.
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4. Outlook and Final Considerations
Bacteria exhibit a wide spectrum of evolutionary, functional and metabolic diversity
that vastly exceeds that of all other organisms. This metabolic versatility has been exploited
for the production of industrially relevant value-added compounds, including top-selling
aromas such as vanillin and carvone. The scientific and technological maturation of
systems biology approaches and genetic engineering tools has fostered advances in modern
microbial biotechnology. As a result, in the last decade, increasing effort has been invested
in the development of bioprocesses for the production of aroma compounds.
Nevertheless, the repertoire of identified gene products and their molecular and bio-
chemical characterization is still scarce, especially regarding acyclic monoterpenes such as
β-myrcene, which limits the setup of biological systems and these plant volatiles as source
of industrially important aromas and novel biomolecules. The development of engineered
cell factories regarding monoterpene biotechnology is in its infancy, for which there are
no reported studies. As the molecular background associated to monoterpene catabolic
pathways is unveiled using holistic characterization approaches, several microbial strains
and their versatile functional repertoire are emerging as prospective biotechnological tools,
such as Pseudomonas sp. M1 and C. defragrans DSM 12143, as well as several engineered
variants of class I P450 cytochromes (Figure 7).
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by functional genomics ethodologies (e.g., Pseudomonas sp. M1, Castellaniella defragrans DSM 12143),
as well as several monoterpene-transforming functional modules, are emerging as prospective
biotechnological tools for the valorization of monoterpene-rich feedstocks.
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The current metabolic engineering rationale results from merging systems biology
approaches with genome-wide engineering platforms (synthetic biology) and directed
evolution strategies, aiming at the tuning and customization of tractable strains to improve
biotransformation performance. Moreover, the comprehensive characterization of the full
biotechnological potential of the reported biological systems is not only limited by the
functional approaches used but also by the maturity of protein and metabolite databases.
Currently, the MetaCyc and KEGG databases of metabolic pathways include molecular in-
formation of only few monoterpene catabolic pathways, reported in C. defragrans (limonene,
β-myrcene and linalool), Rhodococcus spp. (DL-limonene, DL-carveol, DL-dihydrocarveol
and 1,8-cineole), G. stearothermophilus BR388 (D-limonene) and Pseudomonas spp. (camphor,
D-limonene, p-cymene and β-citronellol and geraniol).
Therefore, to bridge the knowledge-to-application gap, the research on monoterpene
biocatalysis must be driven by and include the following key approaches: (i) the detailed
sequencing of the genome of monoterpene-biotransforming strains, followed by accurate
curation of gene annotations; (ii) functional characterization of the monoterpene-induced
stimulon at the transcriptional, translational, metabolic and physiological level towards
the comprehensive understanding of the biological systems and catalytic steps; (iii) the
establishment of tools for precise genetic and protein manipulation, including genome-
wide engineering (e.g., genome streamlining) and targeting specific functional modules
(e.g., catabolic genes, promoter sequences, regulatory elements); (iv) genome-wide in
silico metabolic reconstruction based on experimental data, which will allow further
refinement of the predictive models; (v) the characterization of the biological properties of
new monoterpene derivatives, arising from studies with uncharacterized strains and novel
enzymes, which may generate unprecedented scents and flavors; and (vi) updating of the
curated data into publicly available databases to reach the whole scientific community.
Additionally, future efforts in whole-cell bioprocesses may not only have to focus on
designing orthogonal catalytic steps towards metabolic robustness and proper distribution
of the carbon flux and redox power of the cell, but also aim at controlling the stability of the
desired genetic–physiological trait by limiting phenotypic heterogeneity and cell evolution
within the bacterial population.
Furthermore, the establishment of bioaroma production by using monoterpene pre-
cursors is mostly in initial stages of development and implementation, also due to the
intricate physicochemical properties of monoterpenes and monoterpenoids (e.g., high
hydrophobicity, volatility and structural instability), which may constrain the performance
of biocatalyst, either as whole cells or enzymes, and the production yield in conventional
bioprocess setups based on aqueous catalysis. The successful setup of such biotechnologi-
cal processes may therefore be dependent on key engineering parameters defined at the
genetic (pathway engineering and gene expression), physiological (cytotoxicity, compet-
ing pathways and by-product generation) and technological levels (low-cost substrates,
volatility, ISPR approaches and downstream processing for product recovery, biocatalyst
recycling and reduction of wastes), for which only a systematic approach will allow the
identification of the parameters that play a key role in monoterpene biotransformation, and
subsequently the development of strategies for bioprocess optimization and sustainability.
Supplementary Materials: The following are available: Table S1. Bacterial strains reported to bio-
transform monoterpenes and monoterpenoids Table S2. Bacterial monoterpene-catabolizing modules
characterized at the genetic and/or protein level, envisaging potential biotechnological applica-
tions. Table S3. Bacterial-based systems reported for the biosynthesis of monoterpenes. MVA,
mevalonate pathway; MEP, 2-C-methyl-D-erythritol 4-phosphate pathway; GPPS/IspA, geranyl
diphosphate synthase; Dxs, 1-deoxy-d-xylulose-5-phosphate synthase; Idi, isopentenyl diphos-
phate isomerase; AtoB, acetyl-CoA acetyltransferase, HMGS, hydroxymethylglutaryl-CoA synthase;
HMGR, hydroxymethylglutaryl-CoA reductase; MK, mevalonate kinase; PMK, phosphomevalonate
kinase; PMD, pyrophosphomevalonate decarboxylase.
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